• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者血管通路介入治疗中血管破裂的危险因素。

Risk factors for blood vessel rupture during vascular access intervention therapy for hemodialysis patients.

机构信息

Department of Nephrology, Kanto Rosai Hospital, Kawasaki City, Kanagawa, Japan.

Department of Nephrology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.

出版信息

PLoS One. 2023 Mar 31;18(3):e0283844. doi: 10.1371/journal.pone.0283844. eCollection 2023.

DOI:10.1371/journal.pone.0283844
PMID:37000893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10065258/
Abstract

Blood vessel rupture is a major complication associated with vascular access intervention therapy (VAIVT). However, information regarding the risk factors for ruptures related to VAIVT is limited. The purpose of this study was to investigate the risk factors for rupture during VAIVT. This was a single-center, retrospective observational study. Demographic, clinical, anatomical, and VAIVT procedure variables were reviewed and analyzed using multivariate logistic regression. The 211 patients included in the study underwent 628 VAIVT procedures from November 2019 to December 2021, and 20 blood vessel ruptures occurred. Patients with ruptures had significantly lower BMI (p = 0.043), shorter access vintage(p = 0.017), underwent VAIVT for the first time (p = 0.006), and had lower blood flow quantity (p = 0.005), lower brachial artery flow volume (p = 0.018), and higher resistance index (p = 0.011). The multivariate logistic regression revealed that receiving VAIVT for the first time (OR 5.95, 95%CI 1.01-34.84; p = 0.048) and high resistance index (OR 1.86, 95%CI 1.01-3.16; p = 0.02) were significantly associated with a high risk for rupture. Furthermore, receiver operating characteristic curve analysis to assess the sensitivity-specificity profiles of the resistance index for ruptures showed that the optimal threshold was 0.70 (sensitivity/specificity, 0.69/0.70). Heightened surveillance during vascular access intervention therapy is warranted, especially in patients undergoing VAIVT for the first time or patients with a high resistance index (> 0.70).

摘要

血管破裂是血管介入治疗(VAIVT)相关的主要并发症。然而,关于 VAIVT 相关破裂风险因素的信息有限。本研究旨在探讨 VAIVT 过程中破裂的风险因素。这是一项单中心、回顾性观察研究。使用多变量逻辑回归分析了人口统计学、临床、解剖和 VAIVT 程序变量。本研究共纳入 211 例患者,在 2019 年 11 月至 2021 年 12 月期间接受了 628 次 VAIVT 治疗,其中发生了 20 例血管破裂。破裂组患者的 BMI 显著较低(p = 0.043),血管通路使用时间较短(p = 0.017),首次接受 VAIVT 治疗(p = 0.006),血流量较低(p = 0.005),肱动脉血流量较低(p = 0.018),阻力指数较高(p = 0.011)。多变量逻辑回归显示,首次接受 VAIVT 治疗(OR 5.95,95%CI 1.01-34.84;p = 0.048)和高阻力指数(OR 1.86,95%CI 1.01-3.16;p = 0.02)与破裂风险显著相关。此外,评估阻力指数对破裂的灵敏度-特异性曲线分析显示,最佳阈值为 0.70(灵敏度/特异性,0.69/0.70)。在血管介入治疗期间需要加强监测,特别是在首次接受 VAIVT 治疗或阻力指数较高(> 0.70)的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e739/10065258/af96eeef19ff/pone.0283844.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e739/10065258/af96eeef19ff/pone.0283844.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e739/10065258/af96eeef19ff/pone.0283844.g002.jpg

相似文献

1
Risk factors for blood vessel rupture during vascular access intervention therapy for hemodialysis patients.血液透析患者血管通路介入治疗中血管破裂的危险因素。
PLoS One. 2023 Mar 31;18(3):e0283844. doi: 10.1371/journal.pone.0283844. eCollection 2023.
2
Impact of vascular access intervention therapy on cardiac load in hemodialysis patients.血管通路介入治疗对血液透析患者心脏负荷的影响。
Hemodial Int. 2016 Oct;20 Suppl 1:S12-S16. doi: 10.1111/hdi.12460.
3
Lidocaine-Propitocain Cream, a Eutectic Mixture of Local Anesthetics, Effectively Relieves Pain Associated With Vascular Access Intervention Therapy in Patients Undergoing Hemodialysis: A Placebo-Controlled, Double-Blind, Crossover Study.利多卡因-丙胺卡因乳膏,一种局部麻醉剂的共熔混合物,可有效缓解血液透析患者血管通路介入治疗相关的疼痛:一项安慰剂对照、双盲、交叉研究。
Ther Apher Dial. 2020 Feb;24(1):34-41. doi: 10.1111/1744-9987.12813. Epub 2019 Jun 17.
4
[Does early vascular access intervention therapy reduce acute obstruction and reconstruction of arterial-venous fistula?].
Hinyokika Kiyo. 2006 Sep;52(9):699-703.
5
Use of the Viabahn covered stent for the treatment of venous rupture during interventions of dysfunctional or thrombosed hemodialysis vascular access.使用 Viabahn 覆膜支架治疗功能失调或血栓形成的血液透析血管通路介入治疗期间的静脉破裂。
J Vasc Access. 2021 Sep;22(5):759-766. doi: 10.1177/1129729820961955. Epub 2020 Oct 3.
6
Systematic evaluation of vascular access by color-Doppler ultrasound decreased the incidence of emergent vascular access intervention therapy and X-ray exposure time: a single-center observational study.
Ther Apher Dial. 2012 Apr;16(2):169-72. doi: 10.1111/j.1744-9987.2011.01038.x. Epub 2012 Jan 5.
7
Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography.使用彩色多普勒超声评估经皮腔内血管成形术筛查
J Vasc Access. 2015 Nov;16 Suppl 10:S53-7. doi: 10.5301/jva.5000448. Epub 2015 Aug 27.
8
Trans-collateral angioplasty in vascular access intervention therapy for subacute occluded vessel.
J Vasc Access. 2016 May 7;17(3):e39-41. doi: 10.5301/jva.5000522.
9
Treatment of hemodialysis vascular access rupture irresponsive to prolonged balloon tamponade: retrospective evaluation of the effectiveness of N-butyl cyanoacrylate seal-off technique.治疗对长时间球囊填塞无反应的血液透析血管通路破裂:氰基丙烯酸正丁酯封闭技术有效性的回顾性评估。
Korean J Radiol. 2013 Jan-Feb;14(1):70-80. doi: 10.3348/kjr.2013.14.1.70. Epub 2012 Dec 28.
10
Venous rupture during percutaneous treatment of hemodialysis fistulas and grafts.经皮治疗血液透析瘘管和移植物时发生静脉破裂。
Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1097-101. doi: 10.1002/ccd.22143.

本文引用的文献

1
A retrospective cohort study comparing high and low balloon inflation pressure on technical success and patency for treating central venous lesions in patients on chronic hemodialysis.一项回顾性队列研究比较了高和低球囊充气压力对慢性血液透析患者中心静脉病变治疗的技术成功率和通畅率的影响。
Ren Fail. 2021 Dec;43(1):1281-1287. doi: 10.1080/0886022X.2021.1975741.
2
New Devices and Technologies for Hemodialysis Vascular Access: A Review.新的血液透析血管通路设备和技术:综述。
Am J Kidney Dis. 2021 Jul;78(1):116-124. doi: 10.1053/j.ajkd.2020.11.027. Epub 2021 May 6.
3
[Parameters predicting arterious-venous fistula maturation in pre surgery vascular mapping].
G Ital Nefrol. 2021 Apr 14;38(2):2021-vol2.
4
Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography.经皮腔内血管造影术后动静脉内瘘和移植物早期及晚期再狭窄的相关预测因素。
Ann Transl Med. 2021 Jan;9(2):132. doi: 10.21037/atm-20-7690.
5
The effect of angioplasty of single arteriovenous fistula-associated stenosis on arteriovenous fistula blood flow rate.单动静脉内瘘相关狭窄血管成形术对动静脉内瘘血流量的影响。
J Vasc Access. 2020 Sep;21(5):705-714. doi: 10.1177/1129729819901223. Epub 2020 Jan 29.
6
Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.二甲基精氨酸二甲氨基水解酶 1 多态性与血液透析患者静脉内膜增生。
Am J Nephrol. 2019;50(6):454-464. doi: 10.1159/000503949. Epub 2019 Oct 22.
7
Microcalcification in the arterial wall and its relationship to the ultrasound criteria of maturation of the arteriovenous fistula.动脉壁中的微钙化及其与动静脉内瘘成熟超声标准的关系。
J Vasc Access. 2019 Jan;20(1):46-51. doi: 10.1177/1129729818775359. Epub 2018 Oct 1.
8
A Review of Percutaneous Transluminal Angioplasty in Hemodialysis Fistula.血液透析动静脉内瘘经皮腔内血管成形术综述
Int J Vasc Med. 2018 Mar 27;2018:1420136. doi: 10.1155/2018/1420136. eCollection 2018.
9
Postoperative day 1 access blood flow and resistive index can predict patency in distal forearm arteriovenous fistula.术后第1天的通路血流量和阻力指数可预测前臂远端动静脉内瘘的通畅情况。
J Vasc Access. 2017 Sep 11;18(5):371-378. doi: 10.5301/jva.5000777. Epub 2017 Aug 2.
10
Outcomes of vascular access for hemodialysis: A systematic review and meta-analysis.血液透析血管通路的结局:一项系统评价和荟萃分析。
J Vasc Surg. 2016 Jul;64(1):236-43. doi: 10.1016/j.jvs.2016.01.053.